![Danaher Corp Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/dhr.png?tr=w-200)
Danaher Corp
NYSE:DHR
![Danaher Corp Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/dhr.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
185.1
273.48
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Realty Income Corp
NYSE:O
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/dhr.png)
Intrinsic Value
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. [ Read More ]
The intrinsic value of one
DHR
stock under the Base Case scenario is
190.5
USD.
Compared to the current market price of 273.48 USD,
Danaher Corp
is
Overvalued by 30%.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/dhr.png?tr=w-200)
Valuation Backtest
Danaher Corp
Run backtest to discover the historical profit from buying and selling
DHR
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Danaher Corp
Current Assets | 9.6B |
Cash & Short-Term Investments | 2.4B |
Receivables | 3.9B |
Other Current Assets | 3.3B |
Non-Current Assets | 68.9B |
PP&E | 5.7B |
Intangibles | 60.4B |
Other Non-Current Assets | 2.9B |
Current Liabilities | 6.7B |
Accounts Payable | 1.6B |
Accrued Liabilities | 2.8B |
Other Current Liabilities | 2.3B |
Non-Current Liabilities | 22B |
Long-Term Debt | 16.3B |
Other Non-Current Liabilities | 5.6B |
Earnings Waterfall
Danaher Corp
Revenue
|
22.3B
USD
|
Cost of Revenue
|
-9.1B
USD
|
Gross Profit
|
13.2B
USD
|
Operating Expenses
|
-8.5B
USD
|
Operating Income
|
4.7B
USD
|
Other Expenses
|
-524m
USD
|
Net Income
|
4.2B
USD
|
Free Cash Flow Analysis
Danaher Corp
USD | |
Free Cash Flow | USD |
DHR Profitability Score
Profitability Due Diligence
Danaher Corp's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/dhr.png)
Score
Danaher Corp's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
DHR Solvency Score
Solvency Due Diligence
Danaher Corp's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/dhr.png)
Score
Danaher Corp's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DHR Price Targets Summary
Danaher Corp
According to Wall Street analysts, the average 1-year price target for
DHR
is 277.48 USD
with a low forecast of 227.25 USD and a high forecast of 311.85 USD.
Ownership
DHR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Price Appreciation
DHR Price
Danaher Corp
Average Annual Return | 19.69% |
Standard Deviation of Annual Returns | 29.12% |
Max Drawdown | -44% |
Market Capitalization | 198B USD |
Shares Outstanding | 740 690 000 |
Percentage of Shares Shorted | 1.3% |
DHR News
Last Important Events
Danaher Corp
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Danaher Corp
Company Profile
![Danaher Corp Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/dhr.png?tr=w-200)
![Danaher Corp Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/dhr.png?tr=w-200)
Country
Industry
Market Cap
Dividend Yield
Description
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 78,000 full-time employees. The firm operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solutions segment offers products and services that help protect precious resources and keep global food and water supplies safe.
Contact
IPO
Employees
Officers
The intrinsic value of one
DHR
stock under the Base Case scenario is
190.5
USD.
Compared to the current market price of 273.48 USD,
Danaher Corp
is
Overvalued by 30%.